G Mathé

2.1k total citations
105 papers, 1.4k citations indexed

About

G Mathé is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, G Mathé has authored 105 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 33 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in G Mathé's work include Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). G Mathé is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), Immune Cell Function and Interaction (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). G Mathé collaborates with scholars based in France, Denmark and Germany. G Mathé's co-authors include L Schwarzenberg, Jeanne Amiel, A Cattan, M. Schneider, M. Hayat, O Hallé-Pannenko, M. Schneider, C Bourut, Alain Reinberg and Françis Lévi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

G Mathé

99 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Mathé France 18 403 392 371 285 173 105 1.4k
Maryrose J. Conklyn United States 19 624 1.5× 162 0.4× 1.0k 2.8× 718 2.5× 167 1.0× 38 2.3k
G. D. Ledney United States 21 231 0.6× 196 0.5× 301 0.8× 396 1.4× 40 0.2× 88 1.7k
Sidney R. Smith United States 17 256 0.6× 197 0.5× 924 2.5× 201 0.7× 45 0.3× 39 1.5k
Daniel J. Marmer United States 15 146 0.4× 208 0.5× 432 1.2× 176 0.6× 45 0.3× 30 1.1k
L A Boxer United States 21 148 0.4× 156 0.4× 595 1.6× 392 1.4× 55 0.3× 36 1.4k
JB Weinberg United States 14 82 0.2× 298 0.8× 372 1.0× 321 1.1× 78 0.5× 19 1.2k
D. Ross Boswell New Zealand 22 294 0.7× 263 0.7× 574 1.5× 698 2.4× 41 0.2× 40 2.5k
Christopher J. Bagley Australia 24 294 0.7× 101 0.3× 637 1.7× 673 2.4× 77 0.4× 37 1.8k
Xunxiang Du United States 9 276 0.7× 119 0.3× 773 2.1× 353 1.2× 53 0.3× 10 1.4k
Katarzyna Koziak Poland 19 155 0.4× 118 0.3× 251 0.7× 462 1.6× 80 0.5× 40 1.7k

Countries citing papers authored by G Mathé

Since Specialization
Citations

This map shows the geographic impact of G Mathé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Mathé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Mathé more than expected).

Fields of papers citing papers by G Mathé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Mathé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Mathé. The network helps show where G Mathé may publish in the future.

Co-authorship network of co-authors of G Mathé

This figure shows the co-authorship network connecting the top 25 collaborators of G Mathé. A scholar is included among the top collaborators of G Mathé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Mathé. G Mathé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eriguchi, Masazumi, Y Takeda, Hironobu Yanagië, et al.. (1997). Pilot study for preoperative administration of 1-OHP to patients with advanced scirrhous type gastric cancer. Biomedicine & Pharmacotherapy. 51(5). 217–220. 12 indexed citations
2.
Lévi, Françis, Manuel Benavides, C. Chevelle, et al.. (1990). Chemotherapy of advanced ovarian cancer with 4'-O-tetrahydropyranyl doxorubicin and cisplatin: a randomized phase II trial with an evaluation of circadian timing and dose-intensity.. Journal of Clinical Oncology. 8(4). 705–714. 102 indexed citations
3.
Delépine, N., et al.. (1990). Results of multidisciplinary limb salvage in 240 consecutive bone sarcomas. Biomedicine & Pharmacotherapy. 44(4). 217–224. 3 indexed citations
4.
Bravo‐Cuéllar, Alejandro, et al.. (1989). In vivo immunopharmacological properties of the traditional Chinese medicine Kang Fu-Xin (KFX). 5(1). 25–33. 1 indexed citations
6.
Mathé, G. (1989). Lessons from past experience in cancer immutiotherapy and their application to cancer and AIDS treatment and prophylaxis. Biomedicine & Pharmacotherapy. 43(8). 551–561. 3 indexed citations
7.
Bourut, C, et al.. (1988). On a new class of mixed-function drugs associating nitroimidazoles and CENU: the NICE-NU.. PubMed. 3(1). 57–65. 3 indexed citations
8.
Labarre, P., et al.. (1987). Qualitative and quantitative analysis of a new sulphur-containing nitrosourea in blood by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 419. 381–387. 7 indexed citations
9.
Mathé, G. (1983). [EB virus, immunodeficiency, bone marrow aplasia, malignant mononucleosis and sex-linked lymphoproliferative B syndrome (XLP)].. PubMed. 37(6). 249–50. 1 indexed citations
10.
Hallé-Pannenko, O, Linda L. Pritchard, & G Mathé. (1980). Immunobiology of Minor Histocompatibility Antigens in the Lethal Graft-versus-Host-Reaction Induced in Adult Mice. Hämatologie und Bluttransfusion. 25. 75–91. 6 indexed citations
11.
Rappaport, Henry, et al.. (1979). Comparative study of the histologic reactions to intravenous injections of heat-killed Pseudomonas aeruginosa and of BCG.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(4). 200–5. 3 indexed citations
12.
Mathé, G, J. L. Misset, F. de Vassal, et al.. (1978). Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.. PubMed. 62(5). 805–9. 47 indexed citations
13.
Bruley-Rosset, M., et al.. (1978). Effects of Bacillus Calmette-Guérin and levamisole on immune responses in young adult and age-immunodepressed mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 62(11). 1641–50. 17 indexed citations
14.
Pouillart, P, T Palangié, P Huguenin, et al.. (1978). [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7(4). 265–9. 1 indexed citations
15.
Pouillart, P, et al.. (1975). Effect of bcg on haemopoietic stem cells.. The Mouseion at the JAXlibrary (Jackson Laboratory). 469. 3 indexed citations
16.
Mathé, G. (1974). Current Status of Immunotherapy of Human Cancers. Drugs. 8(6). 411–416. 2 indexed citations
17.
Mathé, G, et al.. (1970). The Immunological Approach to Cancer Treatment. Journal of the Royal College of Physicians of London. 5(1). 62–76. 6 indexed citations
18.
Mathé, G, Jeanne Amiel, L Schwarzenberg, et al.. (1970). Bone Marrow Graft in Man after Conditioning by Antilymphocytic Serum. BMJ. 2(5702). 131–136. 147 indexed citations
19.
Mathé, G, Jeanne Amiel, L Schwarzenberg, A Cattan, & M. Schneider. (1963). Haematopoietic Chimera in Man After Allogenic (Homologous) Bone-marrow Transplantation. BMJ. 2(5373). 1633–1635. 98 indexed citations
20.
Küss, R, et al.. (1961). [Renal homotransplantation in man (apropos of 3 cases)].. PubMed. 87. 183–99. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026